Discovery of cytochrome p450 1B1 inhibitors as new promising anti-cancer agents
- Authors
- Chun, YJ; Kim, SH
- Issue Date
- Nov-2003
- Publisher
- JOHN WILEY & SONS INC
- Keywords
- cytochrome P4501B1; CYPI inhibitors; stilbene; anti-cancer; natural products
- Citation
- MEDICINAL RESEARCH REVIEWS, v.23, no.6, pp 657 - 668
- Pages
- 12
- Journal Title
- MEDICINAL RESEARCH REVIEWS
- Volume
- 23
- Number
- 6
- Start Page
- 657
- End Page
- 668
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/24924
- DOI
- 10.1002/med.10050
- ISSN
- 0198-6325
1098-1128
- Abstract
- Human cytochrome P450 (CYP)1B1 is a major enzyme for carcinogenic estrogen metabolism and involved in the metabolic activation of procarcinogens of the polycyclic aromatic hydrocarbons (PAHs). CYP1B1 is known to be expressed at a high frequency in various human cancers, but not in normal tissues. It also plays an important role in the metabolism of various anticancer drugs. These findings suggest inhibition of CYP1B1 as a new oncological therapeutic strategy. Several natural and synthetic compounds have been studied in an effort to find the isoform-specific inhibitors of the CYP1 subfamily. A survey of the inhibitors of CYP1B1 and other related inhibitors of the CYP1 subfamily is provided in this review. (C) 2003 Wiley Periodicals, Inc.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > ETC > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.